49 A recent systematic review and meta-analysis involving obese individuals without diabetes demonstrated that tirzepatide, semaglutide, liraglutide, and exenatide significantly increased the risk of GI adverse events compared with placebo
How much does GLP-1 weight loss therapy cost
August 2025 : The US FDA approved Wegovy (semaglutide 2.4 mg) for the treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis), in combination with a reduced-calorie diet and increased physical activity
American Society of Retina Specialists
After that ceiling is reached, patients pay full retail pricetypically $1,200+ monthlyfor the remainder of the year, making long-term affordability unpredictable
Yes, GLP-1based medications have received FDA approval for weight loss treatment